Published in
Esmo Open, Esmo Open, 6(9), p. 103446, 2024
DOI: 10.1016/j.esmoop.2024.103446
Links
Tools
A phase II study (AARDVARC) of AZD4635 in combination with durvalumab and cabazitaxel in patients with progressive, metastatic, castration-resistant prostate cancer
Journal article published in 2024 by
T. Alonso-Gordoa 
,
M. Goodman ,
C. Vulsteke ,
G. Roubaud,
J. Zhang,
M. Parikh,
J. M. Piulats,
A. Azaro,
G. D. James,
R. Cavazzina,
E. T. Gangl,
J. Thompson,
G. Pouliot,
R. Kumar,
C. Sweeney
,
M. Goodman ,
C. Vulsteke ,
G. Roubaud,
J. Zhang,
M. Parikh,
J. M. Piulats,
A. Azaro,
G. D. James,
R. Cavazzina,
E. T. Gangl,
J. Thompson,
G. Pouliot,
R. Kumar,
C. Sweeney
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 